These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 39260756)

  • 1. Global burden and cross-country inequalities in six major immune-mediated inflammatory diseases from 1990 to 2021: A systemic analysis of the Global Burden of Disease Study 2021.
    Luo H
    Autoimmun Rev; 2024 Oct; 23(10):103639. PubMed ID: 39260756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019.
    Cao F; He YS; Wang Y; Zha CK; Lu JM; Tao LM; Jiang ZX; Pan HF
    Autoimmun Rev; 2023 Jun; 22(6):103326. PubMed ID: 36958621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 2021.
    Hao C; Ting L; Feng G; Jing X; Ming H; Yang L; Jie Z; Yin J
    Autoimmun Rev; 2024 Sep; ():103621. PubMed ID: 39232989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal trends in cross-country inequalities of stroke and subtypes burden from 1990 to 2021: a secondary analysis of the global burden of disease study 2021.
    Luo Z; Shan S; Cao J; Zhou J; Zhou L; Jiang D; Yao L; Wu J; Ying J; Zhu Y; Song P; Rahimi K
    EClinicalMedicine; 2024 Oct; 76():102829. PubMed ID: 39309727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-standardized incidence, prevalence, and mortality rates of autoimmune diseases in women of childbearing age from 1990 to 2019.
    Cao F; He YS; Sang N; Liu YC; Hu X; Ni QY; Tao LM; Hou SP; Jiang ZX; Pan HF
    Autoimmun Rev; 2023 Nov; 22(11):103450. PubMed ID: 37741529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and projections of inflammatory bowel disease at the global, regional and national levels, 1990-2050: a bayesian age-period-cohort modeling study.
    Zhou JL; Bao JC; Liao XY; Chen YJ; Wang LW; Fan YY; Xu QY; Hao LX; Li KJ; Liang MX; Hu TH; Liu ZJ; Hu YQ
    BMC Public Health; 2023 Dec; 23(1):2507. PubMed ID: 38097968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019.
    Shin YH; Hwang J; Kwon R; Lee SW; Kim MS; ; Shin JI; Yon DK
    Allergy; 2023 Aug; 78(8):2232-2254. PubMed ID: 37431853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-standardized incidence, prevalence, and mortality rates of autoimmune diseases in adolescents and young adults (15-39 years): an analysis based on the global burden of disease study 2021.
    Zhao M; Zhai H; Li H; Wei F; Ma H; Liu Y; Li W; Wei P
    BMC Public Health; 2024 Jul; 24(1):1800. PubMed ID: 38970015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global burden due to modifiable risk factors for autoimmune diseases, 1990-2021: Temporal trends and socio-demographic inequalities.
    Guan SY; Zheng JX; Feng XY; Zhang SX; Xu SZ; Wang P; Pan HF
    Autoimmun Rev; 2024 Dec; 23(12):103674. PubMed ID: 39461487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A global assessment of incidence trends of autoimmune diseases from 1990 to 2019 and predicted changes to 2040.
    Li DP; Han YX; He YS; Wen Y; Liu YC; Fu ZY; Pan HF; Cao F
    Autoimmun Rev; 2023 Oct; 22(10):103407. PubMed ID: 37572826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in deaths and disability-adjusted life-years of stroke attributable to low physical activity worldwide, 1990-2019.
    Li JX; Zhong QQ; Yuan SX; Zhu F
    BMC Public Health; 2023 Nov; 23(1):2242. PubMed ID: 37964255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the disease burden attributable to asbestos in Brazil, China, Kazakhstan, and Russia between 1990 and 2019.
    Chen J; Wang C; Zhang J; Zhang T; Liang H; Mao S; Li H; Wang Z
    BMC Public Health; 2022 Nov; 22(1):2012. PubMed ID: 36324106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the incidence and DALYs of schizophrenia at the global, regional and national levels: results from the Global Burden of Disease Study 2017.
    He H; Liu Q; Li N; Guo L; Gao F; Bai L; Gao F; Lyu J
    Epidemiol Psychiatr Sci; 2020 Jan; 29():e91. PubMed ID: 31928566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inequalities in disease burden and care quality of chronic obstructive pulmonary disease, 1990-2021: Findings from the Global Burden of Disease Study 2021.
    Yao L; Cao J; Cheng S; Shan S; Jiang D; Luo Z; Li S; Hou L; Li X; Song P
    J Glob Health; 2024 Sep; 14():04213. PubMed ID: 39329348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The necessity for popularizing varicella-zoster virus vaccine programs worldwide: An age-period-cohort analysis for the Global Burden of Disease study 2019.
    Zhang W; He Z; Li P; Zeng W; Feng J; Dong X; Lu H
    J Infect Public Health; 2023 Jul; 16(7):1093-1101. PubMed ID: 37224620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global evolving patterns and cross-country inequalities of inflammatory bowel disease burden from 1990 to 2019: a worldwide report.
    Cao L; Dayimu A; Guan X; Duan M; Zeng S; Wang H; Zong J; Sun C; Yang X; Yang X
    Inflamm Res; 2024 Feb; 73(2):277-287. PubMed ID: 38184814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in global burden of diseases attributable to lead exposure in 204 countries and territories from 1990 to 2019.
    Zhou N; Huang Y; Li M; Zhou L; Jin H
    Front Public Health; 2022; 10():1036398. PubMed ID: 36504990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019.
    GBD 2019 IMID Collaborators
    EClinicalMedicine; 2023 Oct; 64():102193. PubMed ID: 37731935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global, regional, and national burden of chronic kidney disease attributable to high sodium intake from 1990 to 2019.
    Liu W; Zhou L; Yin W; Wang J; Zuo X
    Front Nutr; 2023; 10():1078371. PubMed ID: 36937353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global trends in burden of type 2 diabetes attributable to physical inactivity across 204 countries and territories, 1990-2019.
    Yang X; Sun J; Zhang W
    Front Endocrinol (Lausanne); 2024; 15():1343002. PubMed ID: 38469145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.